Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 1/2 × EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 59 Breast Neoplasms 33 Colorectal Neoplasms 32 Neoplasms 31 Ovarian Neoplasms 30 Neoplasm Metastasis 26 Prostatic Neoplasms 23 Melanoma 23 Leukemia, Myeloid, Acute 23 Pancreatic Neoplasms 22 Multiple Myeloma 21 Lung Neoplasms 21 Recurrence 19 Triple Negative Breast Neoplasms 18 Endometrial Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Lymphoma, Non-Hodgkin 17 Lymphoma, Large B-Cell, Diffuse 16 Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Myelodysplastic Syndromes 14 Uterine Cervical Neoplasms 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Glioblastoma 13 Carcinoma, Renal Cell 13 Stomach Neoplasms 12 Lymphoma, Follicular 12 Small Cell Lung Carcinoma 11 Lymphoma, B-Cell 11 Carcinoma, Hepatocellular 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡